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Abstract 
Article concerns data of the comparative analysis of polymorphic options of genes at patients with genital 
endometriosis and women in control group. There were determined CT genotype of rs4374421 LHCGR locus 
(OR=0.76) is protective factor of genital endometriosis, and genetic markers TT rs7753051 IGF2R and AA 
rs6589964 BSX (OR=1.32 and OR=1.38, respectively) are risk factors for genital endometriosis in the women of 
Russia Central Region. 
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Introduction  
Genital endometriosis is a common, chronic, inflammatory and estrogen-dependent gynecological disease. It affects 
10 to 15% of women in their reproductive years and is characterized by the implantation of endometrial (womb 
lining) tissue outside of the uterus (ectopic endometrium) (Bruner-Tran et al., 2013; Churnosov et al., 2015). 
Common locations of ectopic endometrial implantation are the pelvic peritoneum, ovaries, bowel, bladder, and less 
frequently, the pleural cavity, liver and kidneys. Genital endometriosis is diagnosed in 30 to 40% of women with 
infertility and pelvic pain (Rahmioglu et al., 2015). Women frequently experience symptoms of dysmenorrhea 
(painful menstruation), dyspareunia (pain during sexual intercourse), dysuria (pain during urination) and dyschezia 
(difficulty with defecating). 
Genital endometriosis is not uncommon among adolescents. Approximately half of women under 20 years of age 
who have chronic pelvic pain or dyspareunia have the disease (Brosens et al., 2011). About 5% of endometriosis 
cases are seen in postmenopausal women, and exogenous estrogen replacement therapy is suggested to play a role. 
Genital endometriosis develops as a consequence of a combination of genetic predisposition and environmental 
factors (Nyholt et al., 2014). In this connection a considerable number of works are dedicated to study of genetic 
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principles of endometriosis development (Dun et al., 2010; Trabert et al., 2011; Guo et al., 2014; Krivoshei et al., 
2015). Nevertheless it is worth mentioning that the results obtained by different groups of investigators are 
contradictory and do not give an unambiguous answer to the question about the role of genetic factors in pathogenesis 
and clinical features of genital endometriosis. 
Materials and Methods  
There was performed analysis of the observation data for 1398 persons: 403 patients with genital endometriosis and 
995 females from the reference panel. The patients and reference panels included Russian women, natives of the 
Central region of Russia and not having family ties among themselves. Clinical laboratory examination of the patients 
was performed at the gynecology department of the perinatal center of the Bishop Ioasaf Belgorod Regional Clinical 
Hospital. The patients with genital endometriosis were subject to pelvic organs ultrasonography, hysteroscopy with 
the subsequent directional biopsy of the lining of the uterus and histologic examination of the scrape, the procedures 
were performed by means of the common and laboratory methods of examination. 
All the patients with genital endometriosis and the control group samples had typing of five molecular and genetic 
markers: LHCGR c.3441+36573C>T (rs4374421), BSX g.122870683A>C (rs6589964), IGF2R c.*1941T>C 
(rs7753051), ESR1 c.1096+13570G>A (rs3020394), GC c.59-1155G>A (rs222020).  
Venous blood samples with the volume of 8-9 ml drawn from the ulnar vein of the proband were used as a test 
material. Genomic DNA extraction from peripheral blood was performed by the standard method of phenol-
chloroform extraction from frozen venous blood samples (Miller et al., 1988).  
Analysis of the examined loci was carried out by the method of polymerase chain reaction of DNA synthesis with use 
of oligonucleotide primers and probes.  
Associations of alleles and genotypes of the studied DNA-markers with development of genital endometriosis were 
assessed by means of analysis of 2x2 contingency tables which included calculation of test with Yates' correction for 
continuity and odds ratio (OR) with 95% confidence interval.  
Results and discussion  
After examination of 403 women with genital endometriosis and 995 women from the control group, it was 
determined, that the control group is completely commeasurable with sampling of cases with genital endometriosis 
by gender, age, nationality and place of birth, and by height and weight (р>0.05). Main characteristics of the studied 
groups are given in the Table 1. 
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Table 1: Characteristics of the subjects from the case and control groups. 
Characteristics Cases Controls 
Total 403 995 
Age, yrs  36.05±8.06 38.2±10.1 
Weight, kg  58.8±1.8  60.4±2.4  
Height, cm  162.8±4.1 168.5±3.7 
 
Examination of alleles concentration of genes polymorphic markers under study showed that for all the examined 
locuses in the group of patients with genital endometriosis and in population sampling, empiric genotype distribution 
corresponded to the expected one at Hardy-Weinberg equilibrium (p>0.05) (Table 2). 
Table 2: Summary information about the studied polymorphisms. 
Polymorphism Studied 
groups 
Minor allele MAF (%) HWE 
χ2 p 
LHCGR c.3441+36573C>T 
(rs4374421) 
Case C 
30.64 
5.43 >0.05 
LHCGR c.3441+36573C>T 
(rs4374421) 
Control C 31.26 0.90 >0.05 
BSX g.122870683A>C 
(rs6589964) 
Case A 52.23 2.42 >0.05 
BSX g.122870683A>C 
(rs6589964) 
Control A 49.25 2.49 >0.05 
IGF2R c.*1941T>C  
(rs7753051) 
Case C 27.79 0.92 >0.05 
IGF2R c.*1941T>C  
(rs7753051) 
Control C 31.16 3.79 >0.05 
ESR1 c.1096+13570G>A 
(rs3020394) 
Case A 70.84 0.81 >0.05 
ESR1 c.1096+13570G>A 
(rs3020394) 
Control A 70.35 2.57 >0.05 
GC c.59-1155G>A  
(rs222020) 
Case C 13.24 0.10 >0.05 
GC c.59-1155G>A  
(rs222020) 
Control C 11.43 0.38 >0.05 
 
Notes: MAF, minor allele frequency; Hardy – Weinberg equilibrium. P values were calculated using the χ2 test. 
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It was ascertained that the patients with genital endometriosis demonstrated high frequency of genotype TT 
rs7753051 IGF2R (53.10%) as compared to the reference group (46.06%, χ2=5.40, р=0.02, OR=1.32, 95% CI 1.04 – 
1.68). 
Insulin-like growth factor 2 receptor (IGF2R) encodes a receptor for both insulin-like growth factor 2 and mannose 6-
phosphate, although the binding sites for either are located on different segments of the receptor. This receptor 
functions in the intracellular trafficking of lysosomal enzymes, the activation of transforming growth factor beta, and 
the degradation of insulin-like growth factor 2.  
While the 173 related mouse gene shows exclusive expression from the maternal allele, imprinting of the human gene 
appears to be polymorphic, with only a minority of individuals showing expression from the maternal allele (Pyun et 
al., 2014). 
Similar results were obtained in respect to distribution of genotypes of rs6589964 BSX locus: higher frequency of 
AA genotype was detected (1.27 times) in the group of patients with genital endometriosis (29.21%), comparing to 
control group (22.96%, χ2=5.55, р=0.02, OR=1.38, 95%Cl 1.05-1.81). 
DNA binding protein BSX that function as transcriptional activator. Is essentiel for normal postnatal growth and 
nursing. Is an essential factor for neuronal neuropeptide Y and agoutirelated peptide function and locomotory 
behavior in the control of energy balance (Elks et al., 2010). 
Significant differences in genotypes concentrations between patients with genital endometriosis and control patients 
were observed per rs4374421 LHCGR as well: the frequency of CT genotype equaled 44.29% among the control 
group, which was higher than that in the patients with genital endometriosis (37.80%, χ2=4.36, р=0.04, OR=0.76, 
95%Cl 0.59-0.98). 
Luteinizing hormone/choriogon adotropin receptor (LHCGR) encodes the receptor for both luteinizing hormone and 
choriogonadotropin. This receptor belongs to the G-protein coupled receptor 1 family, and its activity is mediated by 
G proteins, which activate adenylate cyclase.  
Mutations in this gene result in disorders of male secondary sexual character development, including familial male 
precocious puberty, also known as testotoxicosis, hypogonadotropic hypogonadism, Leydig cell adenoma with 
precocious puberty, and male pseudohermaphtoditism with Leydig cell hypoplasia (Perry et al., 2014). 
No significant differences between the groups were found regarding to allele and genotype frequencies of the of the 
rs3020394 ESR1 and rs222020 GC genes. 
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Conclusion  
Therefore the results of work allow making a conclusion that CT genotype of rs4374421 LHCGR locus (OR=0.76) is 
protective factor of genital endometriosis, and genetic markers TT rs7753051 IGF2R and AA rs6589964 BSX 
(OR=1.32 and OR=1.38, respectively) are risk factors for genital endometriosis in the women of Russia Central 
Region. 
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